Results 91 to 100 of about 431,499 (141)

QT interval prolongation in patients receiving bedaquiline-based regimens for drug-resistant tuberculosis in Sub-Saharan Africa: A systematic review and meta-analysis. [PDF]

J Clin Tuberc Other Mycobact Dis
Okello MO, Pitua I, Okema JN, Ekwem D, Bongomin F, Olum R.   +5 more
europepmc   +1 more source

Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group. [PDF]

Clin Infect Dis, 2017
Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, Thaden JT, Stryjewski ME, van Duin D, Gram-Negative Committee of the Antibacterial Resistance Leadership Group (ARLG)a.   +9 more
europepmc   +1 more source

Prevalence of Enteric Fever in Febrile Patients: Clinico-Bacteriological and Antimicrobial Profile in South Delhi, India. [PDF]

Cureus
Shafiq S, Shree N, Gunasekaran J, Jain V, Khan A.   +4 more
europepmc   +1 more source

Insights from the docking and molecular dynamics simulation of the Phosphopantetheinyl transferase (PptT) structural model from Mycobacterium tuberculosis. [PDF]

Bioinformation, 2013
Rohini K, Srikumar PS.
europepmc   +1 more source

Success rates of DR-TB patients and associated factors in Tanzania: a six-year cohort study. [PDF]

BMC Infect Dis
Lyakurwa DM, Lekule IA, Mziray SR, Balama RF, Sililo G, Kisonga RM, Yao W, Ai F.   +7 more
europepmc   +1 more source

Magnitude of poor multidrug-resistant tuberculosis treatment outcome among multidrug-resistant tuberculous patients at tertiary hospital, South West Ethiopia. [PDF]

Ann Clin Microbiol Antimicrob
Ararame GG, Nardos H.
europepmc   +1 more source

Numerical study for multi-strain tuberculosis (TB) model of variable-order fractional derivatives. [PDF]

J Adv Res, 2016
Sweilam NH, Al-Mekhlafi SM.
europepmc   +1 more source

Integration of AI and ML in Tuberculosis (TB) Management: From Diagnosis to Drug Discovery. [PDF]

Diseases
Memon S, Bibi S, He G.
europepmc   +1 more source

Linezolid for treatment of chronic extensively drug-resistant tuberculosis. [PDF]

N Engl J Med, 2012
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE.   +27 more
europepmc   +1 more source

Molecular epidemiology and clinical characteristics of drug-resistant Mycobacterium tuberculosis in a tuberculosis referral hospital in China. [PDF]

PLoS One, 2014
Wang Q, Lau SK, Liu F, Zhao Y, Li HM, Li BX, Hu YL, Woo PC, Liu CH.   +8 more
europepmc   +1 more source